Ventyx Biosciences, Inc. Ratios

Ratios Dec2020 Dec2021 Dec2022
Profitability
EBT Margin 2,069.27%59,751.52%
EBIT Margin 1,969.27%67,825.25%
EBITDA Margin 1,969.27%67,825.25%
Operating Margin 1,969.27%67,825.25%
Net Margin 7,869.83%86,159.60%
FCF Margin 1,730.45%39,305.05%
Leverage & Solvency
Interest Coverage Ratio -19.69-678.25
Times Interest Earned -19.69-678.25
Valuation
Enterprise Value 998.89M1,857.14M
Market Capitalization 998.89M1,857.14M
Return Ratios
Return on Sales 20.69%597.52%